96-13515. Department of the Army, Madigan Army Medical Center, Tacoma, Washington; Order Imposing Civil Monetary Penalty  

  • [Federal Register Volume 61, Number 105 (Thursday, May 30, 1996)]
    [Notices]
    [Pages 27106-27107]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-13515]
    
    
    
    -----------------------------------------------------------------------
    
    NUCLEAR REGULATORY COMMISSION
    [Docket No. 030-03368; License No. 46-02645-03; EA 96-004]
    
    
    Department of the Army, Madigan Army Medical Center, Tacoma, 
    Washington; Order Imposing Civil Monetary Penalty
    
    I
    
        Madigan Army Medical Center (MAMC, Licensee) is the holder of NRC 
    Materials License No. 46-02645-03, first issued by the Atomic Energy 
    Commission on May 12, 1960. The Nuclear Regulatory Commission (NRC or 
    Commission) issued its first license amendment to MAMC on May 26, 1977. 
    The license authorizes the Licensee to possess byproduct material of 
    various types and to use such material in implementing a nuclear 
    medicine program in accordance with the conditions specified therein.
    
    II
    
        An inspection and investigation of the Licensee's activities were 
    conducted June 6 through December 21, 1995, following the Licensee's 
    report of medical misadministrations that were discovered in June 1995. 
    The results of the inspection and investigation, documented in a report 
    issued on January 5, 1996, NRC Inspection Report No. 030-03368/95-01 
    and Investigation Report 4-95-027, indicated that the Licensee had not 
    conducted its activities in full compliance with NRC requirements. A 
    predecisional enforcement conference was conducted on January 18, 1996, 
    at the Licensee's facility. A written Notice of Violation and Proposed 
    Imposition of Civil Penalty (Notice) in the amount of $8,000 was served 
    upon the Licensee by letter dated February 22, 1996. The Notice 
    described the nature of the violations, the provisions of the NRC's 
    requirements that the Licensee had violated, and the amount of the 
    civil penalty proposed for the violations.
        The Licensee responded to the Notice in two letters both dated 
    March 21, 1996 (Reply to a Notice of Violation and Answer to a Notice 
    of Violation). In its responses, the Licensee admitted the violations 
    but requested mitigation of the proposed civil penalty based on actions 
    taken by the Madigan Army Medical Center (MAMC) to identify and correct 
    the violations.
    
    III
    
        After consideration of the Licensee's response and the statements 
    of fact, explanation, and argument for mitigation contained therein, 
    the NRC staff has determined, as set forth in the Appendix to this 
    Order, that the violations occurred as described in the Notice, and 
    that the penalty proposed for the violations should be imposed.
    
    IV
    
        In view of the foregoing and pursuant to Section 234 of the Atomic 
    Energy Act of 1954, as amended (Act), 42 U.S.C. 2282, and 10 CFR 2.205, 
    it is hereby ordered that:
        The Licensee pay a civil penalty in the amount of $8,000 within 30 
    days of the date of this Order, by check, draft, money order, or 
    electronic transfer, payable to the Treasurer of the United States and 
    mailed to James Lieberman, Director, Office of Enforcement, U.S. 
    Nuclear Regulatory Commission, One White Flint North, 11555 Rockville 
    Pike, Rockville, MD 20852-2738.
    
    V
    
        The Licensee may request a hearing within 30 days of the date of 
    this Order. Where good cause is shown, consideration will be given to 
    extending the time to request a hearing. A request for extension of 
    time must be made in writing to the Director, Office of Enforcement, 
    U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, and include 
    a statement of good cause for the extension. A request for a hearing 
    should be clearly marked as a ``Request for an Enforcement Hearing'' 
    and shall be addressed to the Director, Office of Enforcement, U.S. 
    Nuclear Regulatory Commission, Washington, D.C. 20555, with a copy to 
    the Commission's Document Control Desk, Washington, D.C. 20555. Copies 
    also shall be sent to the Assistant General Counsel for Hearings and 
    Enforcement at the same address and to the Regional Administrator, NRC 
    Region IV, 611 Ryan Plaza Drive, Suite 400, Arlington, Texas 76011.
        If a hearing is requested, the Commission will issue an Order 
    designating the time and place of the hearing. If the Licensee fails to 
    request a hearing within 30 days of the date of this Order (or if 
    written approval of an extension of time in which to request a hearing 
    has not been granted), the provisions of this Order shall be effective 
    without further proceedings. If payment has not been made by that
    
    [[Page 27107]]
    
    time, the matter may be referred to the Attorney General for 
    collection.
        In the event the Licensee requests a hearing as provided above, the 
    issue to be considered at such hearing shall be: whether, on the basis 
    of the violations admitted by the Licensee, this Order should be 
    sustained.
    
        Dated at Rockville, Maryland, this 20th day of May 1996.
    
        For the Nuclear Regulatory Commission.
    James Lieberman,
    Director, Office of Enforcement.
    
    Appendix--Evaluation and Conclusions
    
        On February 22, 1996, a Notice of Violation and Proposed 
    Imposition of Civil Penalty (Notice) in the amount of $8,000 was 
    issued to Madigan Army Medical Center (MAMC or Licensee) for 
    violations identified during an NRC inspection and investigation. 
    The Licensee responded to the Notice in two letters both dated March 
    21, 1996. The Licensee admitted the violations but requested 
    mitigation of the proposed civil penalty based on actions taken by 
    MAMC to identify and correct the violations.
    
    Restatement of Violations Assessed a Civil Penalty
    
    I. Violations Assessed a Civil Penalty
    
        A. 10 CFR 35.25(a) (1) and (2) require, in part, that a licensee 
    that permits the receipt, possession, use, or transfer of byproduct 
    material by an individual under the supervision of an authorized 
    user shall: (1) instruct the supervised individual in the licensee's 
    written quality management program (QMP); and (2) require the 
    supervised individual to follow the written QMP procedures 
    established by the licensee.
        Item 4 of the licensee's QMP specified, in part, that when 
    computer calculations are performed, an individual who did not make 
    the original calculations will check the dose calculation 
    parameters.
        Contrary to the above, the licensee did not meet the above 
    requirements as specified in the following examples:
        1. As of June 6, 1995, the licensee had not assured that 
    individuals working under the supervision of an authorized user, 
    i.e., the medical physicist and dosimetrist, were adequately 
    instructed in the licensee's written QMP. Specifically, although the 
    medical physicist and dosimetrist had signed a record indicating 
    that they had reviewed department procedures, including the QMP, 
    they had neither received specific instruction in the procedures 
    incorporated in the QMP nor read each of the procedures.
        2. Between February 1994 and May 1995, the licensee took no 
    action to require or assure that individuals working under the 
    supervision of an authorized user, i.e., the medical physicist and 
    dosimetrist, were aware of, or were following, the licensee written 
    QMP procedures established by the licensee. Specifically, computer 
    calculations performed were not checked by an individual who did not 
    make the original calculations. (01012)
        B. 10 CFR 35.32(a) requires, in part, that the licensee 
    establish and maintain a written QMP to provide high confidence that 
    byproduct material or radiation from byproduct material will be 
    administered as directed by the authorized user.
        10 CFR 35.32(a) (3) and (4) require, in part, that the QMP 
    include written policies and procedures to meet the objectives that: 
    (1) final plans of treatment and related calculations for 
    brachytherapy are in accordance with the applicable written 
    directives and (2) that each administration of radiation from 
    brachytherapy is in accordance with the applicable written 
    directive.
        Contrary to the above, between February 1994 and May 1995, the 
    licensee's QMP did not include written procedures that met the above 
    stated objectives. Consequently, in five cases involving patients 
    undergoing brachytherapy treatment during this time period, 
    incorrect data values were entered in a computerized treatment 
    planning system used to develop final treatment plans. The entry of 
    incorrect data resulted in errors in the calculated dose rates 
    identified in final treatment plans, thus causing the administered 
    doses to deviate substantially from the prescribed doses specified 
    in the authorized users' written directives. (01022)
        These violations represent a Severity Level II problem 
    (Supplement VI). Civil Penalty--$8,000
    
    Summary of the Licensee's Request for Mitigation
    
        MAMC responded to the Notice on March 21, 1996, admitting the 
    violations but requesting mitigation of the proposed $8,000 civil 
    penalty based on its actions to identify and correct the violations. 
    MAMC noted in its response that ``NRC enforcement actions are 
    intended to act as a deterrent against future violations and to 
    encourage prompt identification and comprehensive correction of 
    violations.'' MAMC then noted that it had identified the violations 
    and made immediate extensive modifications to the radiation safety 
    program and Quality Management Program (QMP) to ensure that the 
    violations would not recur. MAMC described each of the corrective 
    actions and stated that ``processes have been implemented to ensure 
    compliance with the QMP as well as a broad range of internal 
    controls developed to prevent reoccurrence.'' MAMC stated that a 
    standard civil penalty for a Severity Level II violation ($4,000) 
    should be sufficient, noting that this would more appropriately 
    match the intent of NRC's Enforcement Policy and more accurately 
    reflect MAMC's efforts in identifying and correcting the program 
    deficiencies.
    
    NRC Evaluation of Licensee's Request for Mitigation
    
        The Licensee is correct that among the stated purposes of the 
    NRC Enforcement Policy (NUREG-1600) is to encourage prompt 
    identification and comprehensive correction of violations. In this 
    case, normal application of the enforcement policy guidance in 
    Sections VI.B.2.b and c did in fact result in credit for MAMC's 
    identification of the violations and corrective actions. However, 
    Section VII.A. of the Enforcement Policy provides that civil 
    penalties may be escalated to ensure that the proposed civil penalty 
    reflects the significance of the circumstances and conveys the 
    appropriate regulatory message to the licensee. The violations which 
    led to the misadministrations are of very significant regulatory 
    concern to the NRC.
        There were at least five cases involving patients undergoing 
    brachytherapy treatment where MAMC administered radiation in excess 
    of what was intended before MAMC discovered an error in its 
    computerized treatment planning program. At least one of these 
    patient misadministrations was later determined by medical 
    consultants of the Licensee and the NRC to have had potential 
    adverse health effects for the patient involved.
        It was determined by NRC inspection and investigation that the 
    misadministrations were caused, at least in part, by the Licensee's 
    failure to assure that the MAMC staff was implementing the 
    facility's Quality Management Program (QMP) as required and failure 
    to adequately oversee the QMP. Additional training of the Licensee's 
    personnel and increased management oversight could have prevented 
    the misadministrations. These misadministrations were preventable.
        The violations in this case were classified as a Severity Level 
    II problem in recognition of this fundamental breakdown in the very 
    program that is intended to prevent such misadministrations from 
    occurring. The Enforcement Policy provides at Section VII.A.1(a) 
    that discretion should be considered to escalate civil penalties in 
    cases where problems are categorized at Severity Level I or II. As 
    noted in Section I of the Enforcement Policy, enforcement action 
    should be used not only to encourage identification and prompt, 
    comprehensive correction of violations, but also as a deterrent to 
    emphasize the importance of compliance with NRC requirements. While 
    no violation is acceptable, the fact that these violations were 
    preventable cannot be tolerated. In this case, discretion was 
    clearly warranted to assess a civil penalty to MAMC, notwithstanding 
    application of the identification and corrective action factors, to 
    emphasize the importance of preventing significant 
    misadministrations through supervision, training and management 
    oversight. Considering the significance of the actual effects of the 
    violations and their root causes, it was appropriate and wholly 
    consistent with the Enforcement Policy guidance to deny mitigation, 
    exercise discretion and assess a civil penalty of $8,000.
    
    NRC Conclusion
    
        The NRC concludes that an adequate basis for mitigation of the 
    civil penalty is not provided by the Licensee. The NRC also 
    concludes that the proposed civil penalty of $8,000 is appropriate 
    and should be imposed by order.
    
    [FR Doc. 96-13515 Filed 5-29-96; 8:45 am]
    BILLING CODE 7590-01-P
    
    

Document Information

Published:
05/30/1996
Department:
Nuclear Regulatory Commission
Entry Type:
Notice
Document Number:
96-13515
Pages:
27106-27107 (2 pages)
Docket Numbers:
Docket No. 030-03368, License No. 46-02645-03, EA 96-004
PDF File:
96-13515.pdf